ARCHIVES

NCI Cuts Back Directed Research Funds, Encourages Investigator – Initiated Grants

This article is from The Cancer Letter archive.

Vol. 22 No. 08 | February 23, 1996

Download PDF Visit The Full Archive

Related Articles

Multiple Studies Show Benefit of CTL019, A Personalized Therapy, in CLL and ALL

December 27, 2013

NCI to Spend 40 Percent of Stimulus Funds On Contracts

June 26, 2009

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research

November 15, 1996